• Best Practices New Normal
  • Digital Dentistry
  • Data Security
  • Implants
  • Catapult Education
  • COVID-19
  • Digital Imaging
  • Laser Dentistry
  • Restorative Dentistry
  • Cosmetic Dentistry
  • Periodontics
  • Oral Care
  • Evaluating Dental Materials
  • Cement and Adhesives
  • Equipment & Supplies
  • Ergonomics
  • Products
  • Dentures
  • Infection Control
  • Orthodontics
  • Technology
  • Techniques
  • Materials
  • Emerging Research
  • Pediatric Dentistry
  • Endodontics
  • Oral-Systemic Health

Envista to Acquire Osteogenics Biomedical

Article

Envista has announced that it is acquiring Osteogenics Biomedical to expand in the regenerative therapies and implant arenas.

Envista to Acquire Osteogenics Biomedical

Envista to Acquire Osteogenics Biomedical

Envista Holdings Corporation has announced that it will acquire Osteogenics Biomedical Inc, Allotech LLC, and OBI Biologies. These 3 groups combine to make Osteogenics as a whole.

Osteogenics researches and develops a variety of regenerative therapies and bone grafting products for implant dentistry. According to a press release from Envista, bone grafting and these regenerative therapies promote bone stability, a key aspect in implant dentistry. Envista will expand in the regenerative field through this acquisition, according to CEO Amir Aghdaei.

“Increasing our capabilities in regenerative solutions is consistent with our intention to digitize, personalize, and democratize oral care,” said Aghdaei in the press release. “Osteogenics is a recognized pioneer in membrane technologies used in dental bone grafting procedures. They are a trusted brand and have a proven track record of growth. We are excited to welcome the Osteogenics team to Envista.”

The acquisition is expected to close in the third quarter and is not subject to a financing condition or shareholder vote.

Related Videos
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
CDS 2024: Breaking Down Barriers to Care with Eric Kukucka, DD
GNYDM23 Product Focus: CandidPro with Kristin Lange, VP of Sales at Candid
The Connected Future of Dental CAD/CAM with Max Milz
Greater New York Dental Meeting 2023 – Interview with Edward Goldin, DDS
The 2023 AAID Annual Conference - Interview with Allie Hogan of the Atlantic Implant Institute
The 2023 AAID Annual Conference - Interview with Edward Kusek, DDS
The 2023 AAID Annual Conference - Interview with Aman Bhullar, DMD
The 2023 AAID Annual Conference - Interview with Erin Elliot, DDS
The 2023 AAID Annual Conference - Interview with Sundeep Rawal, DMD
© 2024 MJH Life Sciences

All rights reserved.